Innovation in Pharmaceutical Sciences is a catalyst for progress in drug discovery, development, and patient care. This dynamic field encompasses novel approaches, technologies, and methodologies to address complex health challenges. From the advent of precision medicine to advancements in drug delivery systems, innovation is reshaping the pharmaceutical landscape.
Cutting-edge research in genomics, artificial intelligence, and nanotechnology is driving unprecedented breakthroughs. Personalized medicine tailors treatments to individual characteristics, optimizing efficacy and minimizing side effects. Drug repurposing and repositioning strategies provide innovative solutions for existing medications.
Furthermore, continuous advancements in biopharmaceuticals, gene therapy, and immunotherapy are revolutionizing disease management. Collaborations across disciplines foster interdisciplinary approaches, spurring creativity and accelerating progress. Innovation in Pharmaceutical Sciences is not only about developing new drugs but also improving existing therapies and refining healthcare delivery models. This transformative force is pivotal in addressing global health challenges and enhancing patient outcomes. As we navigate the future of pharmaceutical sciences, innovation remains the key driver of advancements that impact millions of lives worldwide.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia